| Name | baquiloprim |
|---|---|
| Synonyms |
5-{[8-(Dimethylamino)-7-methyl-5-quinolinyl]methyl}-2,4-pyrimidinediamine
baquiloprim 2,4-Pyrimidinediamine, 5-[[8-(dimethylamino)-7-methyl-5-quinolinyl]methyl]- 5-((2,4-Diamino-5-pyrimidinyl)methyl)-8-(dimethylamino)-7-methylquinoline |
| Description | Baquiloprim, an antibiotic, is a selective inhibitor of bacterial dihydrofolate reductases. Baquiloprim possesses in vitro bacteriostatic activity against both Gram-negative and Gram-positive bacteria[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 567.9±60.0 °C at 760 mmHg |
| Molecular Formula | C17H20N6 |
| Molecular Weight | 308.381 |
| Flash Point | 297.2±32.9 °C |
| Exact Mass | 308.174957 |
| PSA | 93.95000 |
| LogP | 2.32 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.719 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Phrases | 22-36/37/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
| RTECS | UV8142576 |